• Explore /
  • Poster
  • / Adjuvant TACE plus lenvatinib as compared with TACE alone in patients with hepatocellular carcinoma at high risk of recurrence after surgery: A prospective controlled study.

Adjuvant TACE plus lenvatinib as compared with TACE alone in patients with hepatocellular carcinoma at high risk of recurrence after surgery: A prospective controlled study.

Abstract Poster

Authors

BIN ZHANG

Bin Zhang

Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China

Bin Zhang , Renan Jin , Junjie Xu , Ming yu Chen , Jiang Chen , Hepan Zhu , Jiasheng Cao , Chao Song , Zaibo Yang , Yewei Zhang , Xiao Liang

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Therapeutics

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 505)

DOI

10.1200/JCO.2024.42.3_suppl.505

Abstract #

505

Poster Bd #

D12

Abstract Disclosures

Similar Posters

First Author: Jia-Yi Wu

First Author: Jin-hong Chen

First Author: Zhibo Zhang

First Author: Zheng Wu